Will Rocket Lab’s (RKLB) New iQPS Deal Reveal Competitive Advantages in Satellite Launch Services?

• On November 5, 2025, Institute for Q-shu Pioneers of Space Inc. (iQPS) announced the successful deployment of its latest Earth-imaging satellite via Rocket Lab’s 74th Electron mission from New Zealand, marking the sixth dedicated launch for iQPS’s SAR constellation.
• With six more dedicated Electron launches secured under a new multi-launch agreement and the upcoming debut of the reusable Neutron rocket, Rocket Lab is positioned as a leading provider for expanding Earth observation networks.
• We’ll examine how Rocket Lab’s expanding role in large-scale satellite constellations could shape its long-term growth prospects and risks.

AI is about to change healthcare. These 32 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

Rocket Lab Investment Narrative Recap

To own Rocket Lab stock, you have to believe in its ability to transition from a reliable small-satellite launcher to a vertically integrated space infrastructure provider, winning bigger, recurring contracts as it ramps Neutron and adds end-to-end satellite solutions. While the recent iQPS satellite launch adds to Rocket Lab’s credibility in Earth observation, it does not fundamentally shift the short-term focus: success or delay with the first Neutron launch remains the most important near-term catalyst, while ongoing high cash burn and dilution risks continue to weigh on the stock.

Among recent developments, Rocket Lab’s follow-on equity offering of US$396.6 million, shortly followed by a new filing to raise up to US$750 million, stands out. These cash injections highlight the intense capital needs for Neutron development and expansion, reinforcing that access to funding is tightly linked to maintaining operational momentum and managing the risk of increased dilution as execution plays out.

However, behind the excitement of new launches, investors should watch closely for signs of tightening capital markets or slower-than-expected contract wins, as...

Read the full narrative on Rocket Lab (it's free!)

Rocket Lab's narrative projects $1.3 billion revenue and $113.4 million earnings by 2028. This requires 37.5% yearly revenue growth and a $344.7 million increase in earnings from -$231.3 million.

Uncover how Rocket Lab's forecasts yield a $58.67 fair value, a 14% upside to its current price.

Exploring Other Perspectives

71 individual fair value estimates from the Simply Wall St Community span from US$8.11 to US$65 per share. With ongoing capital raises and intense investment, opinions on Rocket Lab’s path to profitability span a wide spectrum, explore several viewpoints for a more balanced outlook.

Explore 71 other fair value estimates on Rocket Lab - why the stock might be worth as much as 26% more than the current price!

Build Your Own Rocket Lab Narrative

Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.

• A great starting point for your Rocket Lab research is our analysis highlighting 1 key reward and 2 important warning signs that could impact your investment decision.
• Our free Rocket Lab research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Rocket Lab's overall financial health at a glance.

Curious About Other Options?

These stocks are moving-our analysis flagged them today. Act fast before the price catches up:

• The end of cancer? These 29 emerging AI stocks are developing tech that will allow early identification of life changing diseases like cancer and Alzheimer's.
• We've found 16 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free.
• These 13 companies survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. Discover why before your portfolio feels the trade war pinch.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com